EMILIN1 and neoplasm: This dual function is supported by our in vivo evidence showing that EMILIN-1 loss or degradation promotes tumor progression primarily through disruption of the surrounding microenvironment while also interfering with integrin-dependent cellular signaling pathways—underscoring its integrated role in maintaining tissue homeostasis and restraining tumor growth.